DeA Capital, a De Agostini Group Company, is a vehicle for investments in private equity and alternative asset management.
Phone: +39 02 624 9951
Via Brera, 21
Milan, 20121
Italy
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2018-05-30 | Canepa | Acq - Fin | ||
| 2018-01-16 | Casa Vinicola Botter | Private Equity | ||
| 2015-07-24 | Italchimici | Acq - Fin | Progressio | |
| 2008-05-31 | Migros Turk | Take Private | BC Partners, and Turkven Private Equity | |
| 2007-10-11 | Elixir Pharmaceuticals | Series D | $28M | Angel Healthcare Investors, ARCH Venture Partners, Aspen Ventures, CDIB BioScience Venture Management, Globespan Capital Partners, MPM Capital, Omega Fund Management, Oxford Bioscience Partners, Physic Ventures, Tredegar, and W Capital Partners |
